COMMUNIQUÉS West-GlobeNewswire

EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal [...]
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome
17/12/2025
BERKELEY HEIGHTS, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. ( www.securabio.com ), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced that [...]
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
17/12/2025
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications Collaboration supports [...]
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
SAN CARLOS, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that Mick Hitchcock, Ph.D., Interim Chief Executive [...]
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
17/12/2025
ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
17/12/2025
Clinically meaningful lung function activity, measured by ppFEV 1 and LCI 2.5 , with follow-up through 1 year at dose selected for Phase 2 Durable CFTR transgene expression within target therapeutic range with follow-up [...]
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
17/12/2025
NESS ZIONA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today provided an update [...]
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
17/12/2025
-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an acceptable approvable [...]
Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients
17/12/2025
Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral rebounds Activity shown in Paxlovid ® -ineligible patients, representing a significant population with few effective [...]
Kohope Medical Devices Announces 40% Production Capacity Increase and New Distribution Center to Serve North American Market
17/12/2025
Shanghai Kohope Medical Devices Co., Ltd. invests $2.5 million in facility expansion hub to meet surging demand for syringes and medical needles across United States and Canada. SHANGHAI, Dec. 17, 2025 (GLOBE NEWSWIRE [...]
Festive drinking and hormones: Clue shares science-backed guidance for Christmas
17/12/2025
LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- With office parties, cocktails with friends and end-of-year celebrations in full swing, many of us brace for hangovers without realising that festive drinking can have a real [...]
Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
17/12/2025
VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through [...]
Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering
17/12/2025
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA [...]
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
17/12/2025
COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the [...]
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
17/12/2025
16 December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical [...]
SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS
17/12/2025
SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS A major partnership to accelerate Safe's development in the Spanish market Fleurieux-sur-l’Arbresle – France – December 17, 2025 – 8am - Safe [...]
SAFE ANNONCE LA SIGNATURE D'UN CONTRAT DE DISTRIBUTION STRATEGIQUE EN ESPAGNE AVEC VORTROM BIOLOGICS
17/12/2025
SAFE ANNONCE LA SIGNATURE D'UN CONTRAT DE DISTRIBUTION STRATEGIQUE EN ESPAGNE AVEC VORTROM BIOLOGICS Un partenariat majeur pour accélérer le développement de Safe sur le marché espagnol Fleurieux-sur-l’Arbresle – France [...]
Press release: Availability of the Q4 2025 Aide memoire
17/12/2025
Availability of the Q4 2025 Aide memoire Paris, France – December 17, 2025 . Sanofi announced today that its Q4 2025 Aide memoire is available on the "Investors" page of the company's website: Fourth quarter & full [...]
Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »
17/12/2025
Mise en ligne du document «Q4 2025 Aide mémoire » Paris, France, le 17 décembre 2025 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q4 2025 Aide [...]

Pages